Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).

Petr Krivorotko,Elena Zhiltsova,L. Gigolaeva,A. Emelyanov,Roman Pesotskiy,Sergey Yerechshenko,Kirill Nikolaev,Alexander Komyahov,Olga Ivanova,Tengiz Tabagua,K. Zernov,Vadim T. Ivanov,Zalina Alibekovna Aseeva,Alexander Bessonov,Vladimir Semiglazov

Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).

2021

Petr Krivorotko
Elena Zhiltsova
L. Gigolaeva
A. Emelyanov
Roman Pesotskiy
Sergey Yerechshenko
Kirill Nikolaev
Alexander Komyahov
Olga Ivanova
Tengiz Tabagua
K. Zernov
Vadim T. Ivanov
Zalina Alibekovna Aseeva
Alexander Bessonov
Vladimir Semiglazov

e12616Background: Neoadjuvant chemotherapy (NCT), Triple-negative breast cancer (TNBC) including anthracyclines and taxanes for early stages of TNBC, allows to achieve pathological complete respons...

Keywords:

Medicine
Internal medicine
in patient
Oncology
Pathological
Chemotherapy
Triple-negative breast cancer
Breast cancer
pathological response

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations